Beatrice Society Acquires MindSetting
November 15, 2021
Toronto-based Beatrice Society has acquired Canadian psychedelic-assisted psychotherapy provider MindSetting to accelerate adoption of the MindSetting TRIP Protocol and expand clinician training and psychedelic-enhanced therapy offerings. The acquisition brings MindSetting’s protocol certification program and clinic experience into Beatrice’s education and consumer/therapy-focused platform to broaden clinical access to ketamine-assisted and other psychedelic therapies across Canada.
- Buyers
- Beatrice Society
- Targets
- MindSetting
- Industry
- Healthcare Services
- Location
- Ontario, Canada
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Otsuka Pharmaceutical Acquires Mindset Pharma
August 31, 2023
Biotechnology
Otsuka Pharmaceutical Co., Ltd., through its wholly owned U.S. subsidiary Otsuka America, Inc., agreed to acquire Mindset Pharma Inc. in an all-cash statutory plan of arrangement valued at approximately CAD 80 million. The acquisition adds Mindset’s next-generation psychedelic and non-psychedelic drug discovery assets and synthesis capabilities to Otsuka’s psychiatry and neurology pipeline.
-
Community Psychiatry Acquires MindPath Care Centers
May 11, 2021
Healthcare Services
Community Psychiatry Management, LLC acquired MindPath Care Centers to create a nationally scaled outpatient behavioral health platform, more than doubling locations to 70+ and combining over 350 clinicians. The deal expands access to in-person and telemedicine mental health services, including psychiatry, psychotherapy, TMS and addiction recovery, and positions the combined organization for further growth following Community Psychiatry's recent strategic capital investment.
-
Blackhawk Growth Corp Acquires Trip Pharma Inc.
October 13, 2020
Healthcare Services
Blackhawk Growth Corp. completed the acquisition of all outstanding shares of Trip Pharma Inc., an Edmonton-based psychedelic development and wellness company led by Dr. Krista Leicht. The transaction was satisfied largely with issuance of common shares to Trip Pharma shareholders and brings Trip Pharma into Blackhawk's existing healthcare/cannabis investment portfolio as it pursues clinical research and a psychiatric research clinic focused on psilocybin-based therapies.
-
Stella Acquires U.S. Assets of Field Trip Health
June 27, 2023
Healthcare Services
Stella (Stella MSO, Inc.) acquired the U.S. assets of Field Trip Health & Wellness Ltd., including clinics, technology, research data and leadership to expand its psychedelic and ketamine therapy offerings. The deal brings Field Trip clinics in New York and Washington, D.C. into Stella’s network and adds senior Field Trip executives to Stella’s leadership team to help integrate the assets and scale services.
-
Mindpath Health Acquires Psychiatric Centers at San Diego
March 23, 2022
Healthcare Services
Mindpath Health has acquired Psychiatric Centers at San Diego, adding eight locations and 124 providers to its outpatient behavioral health network. The acquisition expands Mindpath's presence in California—strengthening services including autism therapy and transcranial magnetic stimulation (TMS)—and increases patient access across the greater San Diego area.
-
KKR Acquires Majority Interest in Therapy Brands
April 7, 2021
Software
KKR has agreed to acquire a majority interest in Therapy Brands, a Birmingham-based practice management and EHR software platform for mental, behavioral and rehabilitation healthcare providers. Existing investor PSG will remain a minority shareholder, and sellers include investment funds affiliated with Lightyear Capital, Oak HC/FT and Greater Sum Ventures; financial terms were not disclosed.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.